Women’s Health Diagnostics Market Report

Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women's major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. Chronic diseases, such as heart disease, cancer and stroke, cause more death, illness and disability in the United States than any other cause.  According to the Centers for Disease Control and Prevention (CDC) each year, more than 1.7 million Americans die from a chronic disease, accounting for seven out of every 10 deaths. While chronic disease is the leading cause of death for men and women alike, women face unique health challenges. Thirty-eight percent of women suffer from one or more chronic diseases, compared to 30 percent of men.  Early diagnosis of any medical problem with assistance of diagnostic devices, for example, breast MRI, ultrasound, and bone density testing, is basic. Headways in medicinal science offer rewarding chances to keep a beware of women driven conditions that incorporate infectious diseases, osteoporosis, and breast cancer. This is assessed to work for the market.

Women’s Health Diagnostics Market Outlook

Global women’s health market has been growing at a phenomenal pace in the past few years due to increasing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, rising demand for point of care diagnostic testing, high adoption of diagnostics imaging procedure and high prevalence of infectious diseases such as HIV, and hepatitis in women across the globe. For Instance, As indicated by National Center for Biotechnology Information (NCBI), women are 30.0% more prone to be infected with HIV contrasted with men

Furthermore, high prevalence of infectious diseases in women, growing incidence of chronic and lifestyle-related disorders in women coupled with the growing awareness about fertility testing in women and initiatives taken by government to promote women health awareness also drives the women’s health diagnostics market growth. In addition, advancements in medical science to keep a check on women-centric conditions is likely to offer offer lucrative opportunities for growth of the market. 

Women’s Health Diagnostics Market Segmental Overview

The global Women’s Health Diagnostics Market is segmented by Application, End User and Geography.

Women’s Health Diagnostics Market by Application 

Based on application, the market is categorised into, Osteoporosis Testing, Breast Cancer Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Lab-Based Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, Sexually Transmitted Disease Testing and Ultrasound Tests.  The Osteoporosis segment is sub segmented into Bone Densitometry and In Vitro Blood Tests.  The Breast Cancer Testing segment is further categorised into Mammography, Breast Cancer Tumour Marker Tests, Blood Chemistries and Blood Cell Count Tests, Biopsies and other Diagnostic Imaging Tests.  Further, the Ovarian Cancer segment is further classified into Ovarian Cancer Tumour Marker Tests, Diagnostic Imaging Tests and Others. The Cervical Cancer Testing segment comprises PAP Smear and HPV Testing. Lab-Based Testing segment is sub segmented into Pregnancy Testing and Ovulation Prediction Kits and Fertility Monitors.  Further on, Prenatal Genetic Screening and Carrier Testing is further divided into Cystic Fibrosis, Down Syndrome and Edwards Syndrome, Torch Infections and other diseases. Also, the Infectious Disease testing market sub segmented includes Methicillin-Resistant Staphylococcus Aurea (MRSA), Urinary Tract Infections (Vaginal Ph & Vaginitis), Hepatitis, Tuberculosis, and others.  The Sexually Transmitted Disease Testing segment is further bifurcated into Chlamydia Trachomatis and Neisseria Gonorrohoeae Testing, HIV testing and other Sexually Transmitted Diseases. The Ultrasound segment comprises Breast Imaging and Obstetrical and Gynaecological Imaging.

The demand for breast cancer testing market is growing due to the high prevalence of breast cancer across the globe. Breast cancer is the most frequent cancer among women. As per World Health Organisation Data, breast cancer is impacting 2.1 million women each year.  In 2018, it is estimated that 627,000 women died from breast cancer. The breast cancer mortality rate is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally.

Women’s Health Diagnostics Market by End User 

Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care.   The Hospitals & Clinics is expected to record a larger contribution of the global women’s health diagnostic market because fact that a larger proportion of patients (women) go to hospitals for the diagnosis/treatment of their health issues. 

Women’s Health Diagnostics Market by Geography

The women’s health diagnostics market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global Women’s Health Diagnostics Market in 2018. The large share of the market is attributed to the factors such as the rising incidence of breast cancer coupled with the easy accessibility and high adoption of advanced diagnostic technologies, significant per capita annual healthcare expenditure in the US and Canada, and the rapidly increasing geriatric population in the region. Further, growing incidence of lifestyle related health disorders, rising focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors are also the major factiors attributed to the growth of the market. 

However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. A number of factors, such as the growing patient populace, improving healthcare infrastructure, rising government spending on breast cancer research studies, growing healthcare expenditure and implementation of several initiatives to create awareness about the early detection of breast cancer are expected to drive the market in the Asia-Pacific region during the forecast period. 

Women’s Health Diagnostics Market Key Players 

Some of the key players operating in the global Women’s Health Diagnostics Market Siemens AG, Quest Diagnostics Inc., Hologic, Inc., Koninklijke Philips N.V., Biomérieux SA, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche AG, Perkinelmer Inc., Alere Inc. and GE Healthcare among others.